Suppression of IL-12 transcription in macrophages following Fcγ receptor ligation

Journal of Immunology

Volumn 166, Issue 7, 2001, Pages 4498-4506

  Grazia Cappiello, M ^a   Sutterwala, F S ^a   Trinchieri, G ^a   Mosser, D M ^a   Ma, X ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; FC RECEPTOR; INTERLEUKIN 12; PROTEIN P35; PROTEIN P40; TRANSCRIPTION FACTOR REL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; GENE EXPRESSION; GENE MAPPING; GENETIC TRANSCRIPTION; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SECRETION; TRANSCRIPTION REGULATION;

EID: 0035313284     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.7.4498     Document Type: Article

References (43)

1. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response
2. Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction
3. Recombinant interleukin 12 cures mice infected with Leishmania major
4. Resolution of cutaneous leishmaniasis: Interleukin 12 initiates a protective T helper type I immune response
5. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice
6. Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice
7. Interleukin 12 administration induces T helper type I cells and accelerates autoimmune diabetes in NOD mice
8. Selective suppression of interleukin-12 induction after macrophage receptor ligation
9. Regulation of interleukin-12 by complement receptor 3 signaling
10. Mechanism of suppression of cell-mediated immunity by measles virus
11. CD47 ligation selectively downregulates human interleukin 12 production
12. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production
13. 2-agonists prevent Th1 development by selective inhibition of interleukin 12
14. Interleukin-12: A cytokine at the interface of inflammation and immunity
15. Regulation of interleukin 12 p40 expression through an NF-κB half-site
16. The interleukin 12 p40 gene promoter is primed by interferon γ in monocytic cells
17. Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: Evidence of functional synergy between C/EBP and Rel proteins
18. Identification and characterization of a novel Ets-2-related nuclear complex implicated in the activation of the human interleukin-12 p40 gene promoter
19. Synergistic regulation of the human interleukin-12 p40 promoter by NFκB and Ets transcription factors in Epstein-Barr virus-transformed B cells and macrophages
20. Rapid and selective remodeling of a positioned nucleosome during the induction of IL-12 p40 transcription
21. Interferon-γ-dependent inducible expression of the human interleukin-12 p35 gene in monocytes initiates from a TATA-containing promoter distinct from the CpG-rich promoter active in Epstein-Barr vires-transformed lymphoblastoid cells
22. Structure and chromosomal location of the mouse interleukin-12 p35 and p40 subunit genes
23. Expression of murine IL-12 is regulated by translational control of the p35 subunit
24. Disparate intracellular processing of human Il-12 preprotein subunits: Atypical processing of the P35 signal peptide
25. Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation
26. Role of PU.1 in hematopoiesis
27. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
28. The transcription factor PU.1 is involved in macrophage proliferation
29. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
30. The Ets-related transcription factor PU.1 immortalizes erythroblasts
31. Regulation of B lymphocyte and macrophage development by graded expression of PU.1
32. PU.1 recruits a second nuclear factor to a site important for immunoglobulin κ 3′ enhancer activity
33. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator
34. PU.1/Pip and basic helix loop helix zipper transcription factors interact with binding sites in the CD20 promoter to help confer lineage- and stage-specific expression of CD20 in B lymphocytes
35. PU.1, interferon regulatory factor 1, and interferon consensus sequence-binding protein cooperate to increase gp91(phox) expression
36. Mutation analysis of the Pip interaction domain reveals critical residues for protein-protein interactions
37. Reversal of proinflammatory responses by ligating the macrophage Fcγ receptor type I
38. Normal myeloid development requires both the glutamine-rich transactivation domain and the PEST region of transcription factor PU.1 but not the potent acidic transactivation domain
39. Rapid detection of octamer binding proteins with "mini-extracts." prepared from a small number of cells
40. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
41. Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB
42. An IFN-γ-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages
43. Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages